James Lorens
25Patents
5h-index
28Co-inventors
69Inventor score
Filing activity: Apr 17, 1998 → Nov 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6391582B2 | Shuttle vectors | Chemistry; Metallurgy | 64 | Expired |
| US6280937A | Shuttle vectors | Chemistry; Metallurgy | 17 | Expired |
| US6461813B2 | Multiparameter FACS assays to detect alterations in cell cycle regulation | Physics | 8 | Expired |
| US7252952B2 | In vivo production of cyclic peptides for inhibiting protein—protein interaction | Physics | 8 | Expired |
| US8735064B2 | Methods for creating and identifying functional RNA interference elements | Chemistry; Metallurgy | 7 | Active |
| US7527936B2 | Modulators of angiogenesis | Physics | 5 | Expired |
| US9040462B2 | In vivo production of cyclic peptides for inhibiting protein-protein interaction | Chemistry; Metallurgy | 4 | Active |
| US7378248B2 | In vivo production of cyclic peptides for inhibiting protein-protein interaction | Chemistry; Metallurgy | 4 | Expired |
| US7485414B2 | Modulators of angiogenesis | Chemistry; Metallurgy | 3 | Expired |
| US11198734B2 | Anti-Axl antagonistic antibodies | Chemistry; Metallurgy | 2 | Active |
| US7419779B2 | Modulators of angiogenesis | Chemistry; Metallurgy | 2 | Expired |
| US6645766B2 | Shuttle vectors | Chemistry; Metallurgy | 2 | Expired |
| US7205130B2 | Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use | Physics | 2 | Expired |
| US6897031B1 | Multiparameter FACS assays to detect alterations in exocytosis | Physics | 1 | Expired |
| US10208121B2 | Anti-Axl antagonistic antibodies | Physics | 1 | Active |
| US7056687B2 | Methods and compositions for screening for altered cellular phenotypes | Physics | 1 | Expired |
| US7566546B2 | Modulators of angiogenesis and tumorigenesis | Physics | 0 | Expired |
| US9783801B2 | Methods for creating and identifying functional RNA interference elements | Chemistry; Metallurgy | 0 | Active |
| US11534440B2 | Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US8574827B2 | Modulators of angiogenesis and tumorigenesis | Physics | 0 | Active |
| US6623980B1 | Exo1 and Exo2, exocytotic proteins | Chemistry; Metallurgy | 0 | Expired |
| US7244576B2 | Modulators of angiogenesis | Physics | 0 | Expired |
| US8334238B2 | Multiparameter FACS assays to detect alterations in cellular parameters and to screen small molecule libraries | Physics | 0 | Expired |
| US11732048B2 | Anti-axl antagonistic antibodies | Chemistry; Metallurgy | 0 | Active |
| US11584796B2 | Anti-Axl antagonistic antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.